Skip to main content

Table 2 Glycocalyx and endothelial dysfunction markers of patients according to selected group

From: Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction

 

Healthy controls

n = 30

Transplant

n = 30

CKD

n = 32

Dialysis

n = 33

p-value

PBR (µm)

2.05 ± 0.3

2.06 ± 0.28

2.07 ± 0.27

2.01 ± 0.35

0.89

Hyaluronan (ng/mL)

23 (8-116)

57 (14–218)

79 (11–257)

137 (16-1414)

< 0.001

Syndecan-1 (ng/mL)

30 (12–138)

39 (23–72)

46 (21–134)

81 (40–529)

< 0.001

vWF (mIU/mL)

1685 ± 689

2016 ± 653

3076 ± 946

3920 ± 1755

< 0.001

VCAM-1 (ng/mL)

598 (345–1189)

927 (602–1813)

1176 (559–3046)

1479 (737–2900)

< 0.001

uACR (mg/mmol)

0.4 (0-1.9)

5 (0–35)

30 (0-730)

-

0.002